Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Feb 8;8(15):24828–24839. doi: 10.18632/oncotarget.15192

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © 2017 Ying et al.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC-BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

PMC Copyright notice

A. Comparison of the titer of anti-GRP78 autoantibodies in HCC with the other groups. B. Comparison the titer of anti-GRP78 autoantibodies in early-HCC with the other groups. C. Titer of anti-GRP78 autoantibodies in sera from HCC patients with different clinical stages. D. Titer of anti-GRP78 autoantibodies from HCC patients with and without portal vein invasion and metastasis. E. The comparision of anti-GRP78 autoantibodies in sera from HCC patients before treatment and within 1 week after treatment. F. The comparision of anti-GRP78 autoantibodies in sera from HCC patients with recurrence before surgery, within 1 week after surgery, and 1 month after surgery. GRP78, 78 kDa glucose regulated protein; NHS, normal human serum; CH, chronic hepatitis; LC, liver cirrhosis; HCC, hepatocellular carcinoma; NPVI, non-portal vein invasion; PVI, portal vein invasion; NM, non-metastasis; M, metastasis; 1, before surgery; 2, within 1 week after surgery; 3, 1 month after surgery.